Strata Critical Medical (SRTA) Change in Cash (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Change in Cash data on file, last reported at $27.8 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $27.8 million, up 73.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.3 million (up 1082.25% YoY), and the FY2025 annual result was $11.6 million, up 223.59% from the prior year.
• Change in Cash climbed to $27.8 million in Q1 2026 per SRTA's latest filing, from $8.2 million in the prior quarter.
• Over five years, Change in Cash peaked at $185.0 million in Q2 2022 and troughed at -$37.3 million in Q3 2025.
• A 5-year average of $13.4 million and a median of -$604000.0 in 2023 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 1596.52% in 2024 and fell as far as 521.98% in 2024.
• A 5-year view of Change in Cash shows it stood at $185.0 million in 2022, then plunged by 105.0% to -$9.3 million in 2023, then soared by 80.99% to -$1.8 million in 2024, then surged by 567.08% to $8.2 million in 2025, then jumped by 237.82% to $27.8 million in 2026.
• Business Quant data shows SRTA's Change in Cash at $27.8 million in Q1 2026, $8.2 million in Q4 2025, and -$37.3 million in Q3 2025.